Amsterdam UMC spin-off FiglinQ takes off
January 31, 2022Amsterdam UMC researcher Dr. Przemek Krawczyk has developed FiglinQ: a cloud-based, collaborative platform for analysis, interactive plotting and publishing of research data in smart manuscripts. Earlier this year, Przemek was awarded an IXA Proof of Concept grant to launch FiglinQ, and since then several big milestones have been achieved: In June, the first smart
manuscript generated with the use of FiglinQ was published in Nature. Later, FiglinQ received enthusiastic reactions from Elsevier and Springer-Nature. In December 2021, the spin-off company FiglinQ BV was incorporated. And shortly after the incorporation, an NWO Take Off Phase II loan of €250.000 was granted to FiglinQ BV to further develop and improve several key features of the platform, generate stable revenue streams and raise capital for further growth.
- Related news item: Paper published with Amsterdam UMC developed smart manuscript platform
- Dr. Przemek Krawczyk was pre-finalist for the Amsterdam Science & Innovation Award 2021, see here his video about FiglinQ.
More news
PULSE Sport Wins Prestigious Dutch Sports Innovation Award 2024
PULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
News
Biotech boost(er) for life sciences innovations
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
News
Start-up VU-AMS has big plans with clever stress monitoring device
VU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
News